Common Stock, Shares, Outstanding of BioRestorative Therapies, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BioRestorative Therapies, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • BioRestorative Therapies, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 7,978,117, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BioRestorative Therapies, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 7,978,117 +1,058,198 +15% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 7,978,117 +1,058,198 +15% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 7,504,780 +734,861 +11% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 6,919,919 +2,213,002 +47% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 6,919,919 +2,252,278 +48% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 6,919,919 +2,937,311 +74% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 6,769,919 +3,002,304 +80% 31 Mar 2024 10-Q 11 Jun 2024 2024 Q1
Q4 2023 4,706,917 +1,029,142 +28% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 4,667,641 +1,021,191 +28% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 3,982,608 +338,899 +9.3% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 3,767,615 +135,896 +3.7% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 3,677,775 +157,384 +4.5% 31 Dec 2022 10-K/A 11 Jun 2024 2023 FY
Q3 2022 3,646,450 +2,774,255 +318% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 3,643,709 -3,344,134,981 -100% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 3,631,719 -3,172,280,236 -100% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 3,520,391 +2,804,847 +392% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 872,195 -1,593,779,188 -100% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 3,347,778,690 +1,753,127,307 +110% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 3,175,911,955 +1,581,260,572 +99% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 715,544 -77,136,089 -99% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 1,594,651,383 +1,570,933,629 +6623% 30 Sep 2020 10-Q 12 Apr 2021 2020 Q3
Q2 2020 1,594,651,383 +1,574,857,906 +7956% 30 Jun 2020 10-Q 12 Apr 2021 2020 Q2
Q1 2020 1,594,651,383 +1,579,918,972 +10724% 31 Mar 2020 10-Q 29 Mar 2021 2020 Q1
Q4 2019 77,851,633 +66,123,239 +564% 31 Dec 2019 10-K 30 Apr 2021 2020 FY
Q3 2019 23,717,754 +14,995,915 +172% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 19,793,477 +13,045,976 +193% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 14,732,411 +8,249,158 +127% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 11,728,394 +5,615,921 +92% 31 Dec 2018 10-K 18 Mar 2021 2019 FY
Q3 2018 8,721,839 +3,116,382 +56% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 6,747,501 +1,255,896 +23% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 6,483,253 +1,152,206 +22% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 6,112,473 +1,413,438 +30% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 5,605,457 +1,168,305 +26% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 5,491,605 +1,347,039 +33% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 5,331,047 +1,400,229 +36% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 4,699,035 +1,388,306 +42% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 4,437,152 +1,582,884 +55% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 4,144,566 +1,354,135 +49% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 3,930,818 -33,260,734 -89% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 3,310,729 +1,613,065 +95% 31 Dec 2015 10-K 22 Mar 2017 2016 FY
Q3 2015 2,854,268 -28,164,660 -91% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 2,790,431 -22,224,813 -89% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 37,191,552 +15,358,538 +70% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 1,697,664 -17,376,888 -91% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 31,018,928 +13,909,150 +81% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 25,015,244 +8,274,286 +49% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 21,833,014 +5,420,169 +33% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 19,074,552 +4,189,689 +28% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 17,109,778 -672,719,633 -98% 30 Sep 2013 10-Q 19 Nov 2013 2013 Q3
Q2 2013 16,740,958 -656,338,453 -98% 30 Jun 2013 10-Q 19 Aug 2013 2013 Q2
Q1 2013 16,412,845 -611,579,066 -97% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 14,884,863 -592,798,948 -98% 31 Dec 2012 10-K 11 Apr 2014 2013 FY
Q3 2012 689,829,411 +114,568,700 +20% 30 Sep 2012 10-Q 05 Nov 2012 2012 Q3
Q2 2012 673,079,411 +116,366,800 +21% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 627,991,911 31 Mar 2012 10-Q/A 01 Jun 2012 2012 Q1
Q4 2011 607,683,811 +174,466,311 +40% 31 Dec 2011 10-K 02 Apr 2013 2012 FY
Q3 2011 575,260,711 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
Q2 2011 556,712,611 30 Jun 2011 10-Q/A 14 Sep 2011 2011 Q2
Q4 2010 433,217,500 31 Dec 2010 10-K 16 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.